Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
- A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes cellular inflammation and restores...
Brain
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or...
Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)
As interest in the gelatin trick surges in 2026, consumers across social platforms and search engines are asking whether the...
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and...
Zeto Announces 2026 Clinical Trial Sponsorship Winners Advancing EEG in Stroke, Delirium, and Epilepsy
RALEIGH, N.C., March 27, 2026 /PRNewswire/ -- Zeto, Inc., a medical technology company working to make brain health insights through EEG...
ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC
Company to host a conference call and webcast on Tuesday, March 31, 2026 at 4:30 pm ETSOUTH SAN FRANCISCO, Calif....
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer
On track to share data from first two dose levels in 2H 2026 Targeting KLK3 and leveraging the dual emission...
National Cancer Institute Awards Rosalind Franklin University Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
NORTH CHICAGO, Ill., March 26, 2026 /PRNewswire/ -- Rosalind Franklin University announced today that Paige Arneson-Wissink, PhD, assistant professor of...
ALYZE Introduces the Most Comprehensive Personal Health Assessment Outside a Hospital
A data-driven health assessment platform combining advanced diagnostics, biomarker testing, and performance analytics to deliver personalized protocols and guaranteed measurable...
Linus Health Receives Provista Contract for Early Cognitive Detection Solution
Supplier agreement expands access for physician practices to AI-driven tools for proactive brain healthBOSTON, March 26, 2026 /PRNewswire/ -- Linus...
Arizona Femtech Startup Prickly Pear Health Expands Pre-Seed Funding to more than $600K With Investment From Emmeline Ventures
Women-led venture firm joins existing investors to accelerate growth of AI-powered brain health platform for womenPHOENIX, March 26, 2026 /PRNewswire/...
Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer’s Disease Therapies
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutionsCollaboration expected to leverage...
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
Caris AI Insights are proprietary algorithms only available to Caris Life Sciences customers and not achievable through small panelsIRVING, Texas,...
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
-- European Commission decision anticipated in second quarter of 2026 -- BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals,...
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline’s Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline’s Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...
Firefly Confirms Public-Private Partnership with the Department of War
Firefly’s AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service...
Firefly Confirms Public-Private Partnership with the Department of War
Firefly’s AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service...
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...